Clinical translation of nitrite therapy for cardiovascular diseases

Nitric Oxide - Biology and Chemistry

Volumn 22, Issue 2, 2010, Pages 91-97

  Calvert, John W ^a   Lefer, David J ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Hypertension; Nitrite; Stroke

Indexed keywords

ALTEPLASE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRITE; SODIUM NITRITE;

ACUTE HEART INFARCTION; ANGIOGENESIS; BRAIN ARTERY ANEURYSM; BRAIN BLOOD FLOW; BRAIN VASOSPASM; CARDIOVASCULAR DISEASE; CELL PROTECTION; CHRONIC LUNG DISEASE; CLINICAL TRIAL; DRUG EFFECT; HUMAN; HYPERTENSION; ISCHEMIA; LIVER TRANSPLANTATION; LOW DRUG DOSE; LUNG EMBOLISM; LUNG TRANSPLANTATION; MIDDLE CEREBRAL ARTERY OCCLUSION; NEWBORN PRIMARY PULMONARY HYPERTENSION; NITROGEN METABOLISM; NONHUMAN; PERIPHERAL VASCULAR DISEASE; PREOPERATIVE CARE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REPERFUSION INJURY; REVIEW; SICKLE CELL ANEMIA; STROKE; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; WOUND HEALING;

ANIMALS; CARDIOVASCULAR DISEASES; HUMANS; NITRITES; TRANSLATIONAL RESEARCH;

ANIMALIA;

EID: 75149165093     PISSN: 10898603     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.niox.2009.11.001     Document Type: Review

References (83)

1. Grau M., Hendgen-Cotta U.B., Brouzos P., Drexhage C., Rassaf T., Lauer T., Dejam A., Kelm M., and Kleinbongard P. Recent methodological advances in the analysis of nitrite in the human circulation: nitrite as a biochemical parameter of the l-arginine/NO pathway. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 851 1-2 (2007) 106-123
2. Bryan N.S., Fernandez B.O., Bauer S.M., Garcia-Saura M.F., Milsom A.B., Rassaf T., Maloney R.E., Bharti A., Rodriguez J., and Feelisch M. Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat. Chem. Biol. 1 5 (2005) 290-297
3. Kleinbongard P., Dejam A., Lauer T., Rassaf T., Schindler A., Picker O., Scheeren T., Godecke A., Schrader J., Schulz R., Heusch G., Schaub G.A., Bryan N.S., Feelisch M., and Kelm M. Plasma nitrite reflects constitutive nitric oxide synthase activity in mammals. Free Radic Biol. Med. 35 7 (2003) 790-796
4. Lundberg J.O., and Govoni M. Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic Biol. Med. 37 3 (2004) 395-400
5. Lundberg J.O., and Weitzberg E. NO generation from nitrite and its role in vascular control. Arterioscler. Thromb. Vasc. Biol. 25 5 (2005) 915-922
6. Lundberg J.O., Weitzberg E., Cole J.A., and Benjamin N. Nitrate, bacteria and human health. Nat. Rev. Microbiol. 2 7 (2004) 593-602
7. Lundberg J.O., Weitzberg E., and Gladwin M.T. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 7 2 (2008) 156-167
8. Furchgott R.F. Endothelium-derived relaxing factor: discovery, early studies, and identification as nitric oxide. Biosci. Rep. 19 4 (1999) 235-251
9. Johnson III G., Tsao P.S., Mulloy D., and Lefer A.M. Cardioprotective effects of acidified sodium nitrite in myocardial ischemia with reperfusion. J. Pharmacol. Exp. Ther. 252 1 (1990) 35-41
10. Calvert J.W., and Lefer D.J. Myocardial protection by nitrite. Cardiovasc. Res. 83 2 (2009) 195-203
11. Zweier J.L., Wang P., Samouilov A., and Kuppusamy P. Enzyme-independent formation of nitric oxide in biological tissues. Nat. Med. 1 8 (1995) 804-809
12. Samouilov A., Kuppusamy P., and Zweier J.L. Evaluation of the magnitude and rate of nitric oxide production from nitrite in biological systems. Arch. Biochem. Biophys. 357 1 (1998) 1-7
13. Webb A., Bond R., McLean P., Uppal R., Benjamin N., and Ahluwalia A. Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage. Proc. Natl. Acad. Sci. USA 101 37 (2004) 13683-13688
14. Duranski M.R., Greer J.J., Dejam A., Jaganmohan S., Hogg N., Langston W., Patel R.P., Yet S.F., Wang X., Kevil C.G., Gladwin M.T., and Lefer D.J. Cytoprotective effects of nitrite during in vivo ischemia-reperfusion of the heart and liver. J. Clin. Invest. 115 5 (2005) 1232-1240
15. Baker J.E., Su J., Fu X., Hsu A., Gross G.J., Tweddell J.S., and Hogg N. Nitrite confers protection against myocardial infarction: role of xanthine oxidoreductase, NADPH oxidase and K(ATP) channels. J. Mol. Cell. Cardiol. 43 4 (2007) 437-444
16. Lu P., Liu F., Yao Z., Wang C.Y., Chen D.D., Tian Y., Zhang J.H., and Wu Y.H. Nitrite-derived nitric oxide by xanthine oxidoreductase protects the liver against ischemia-reperfusion injury. Hepatobiliary Pancreat. Dis. Int. 4 3 (2005) 350-355
17. Jung K.H., Chu K., Ko S.Y., Lee S.T., Sinn D.I., Park D.K., Kim J.M., Song E.C., Kim M., and Roh J.K. Early intravenous infusion of sodium nitrite protects brain against in vivo ischemia-reperfusion injury. Stroke 37 11 (2006) 2744-2750
18. Tripatara P., Patel N.S., Webb A., Rathod K., Lecomte F.M., Mazzon E., Cuzzocrea S., Yaqoob M.M., Ahluwalia A., and Thiemermann C. Nitrite-derived nitric oxide protects the rat kidney against ischemia/reperfusion injury in vivo: role for xanthine oxidoreductase. J. Am. Soc. Nephrol. 18 2 (2007) 570-580
19. Pluta R.M., Dejam A., Grimes G., Gladwin M.T., and Oldfield E.H. Nitrite infusions to prevent delayed cerebral vasospasm in a primate model of subarachnoid hemorrhage. JAMA 293 12 (2005) 1477-1484
20. Tsuchiya K., Kanematsu Y., Yoshizumi M., Ohnishi H., Kirima K., Izawa Y., Shikishima M., Ishida T., Kondo S., Kagami S., Takiguchi Y., and Tamaki T. Nitrite is an alternative source of NO in vivo. Am. J. Physiol. Heart Circ. Physiol. 288 5 (2005) H2163-H2170
21. Shiva S., Sack M.N., Greer J.J., Duranski M., Ringwood L.A., Burwell L., Wang X., MacArthur P.H., Shoja A., Raghavachari N., Calvert J.W., Brookes P.S., Lefer D.J., and Gladwin M.T. Nitrite augments tolerance to ischemia/reperfusion injury via the modulation of mitochondrial electron transfer. J. Exp. Med. 204 9 (2007) 2089-2102
22. Lefer A.M., and Lefer D.J. Nitric oxide. II. Nitric oxide protects in intestinal inflammation. Am. J. Physiol. 276 3 Pt 1 (1999) G572-G575
23. Jones S.P., and Bolli R. The ubiquitous role of nitric oxide in cardioprotection. J. Mol. Cell. Cardiol. 40 1 (2006) 16-23
24. Sharp B.R., Jones S.P., Rimmer D.M., and Lefer D.J. Differential response to myocardial reperfusion injury in eNOS-deficient mice. Am. J. Physiol. Heart Circ. Physiol. 282 6 (2002) H2422-H2426
25. Jones S.P., Girod W.G., Palazzo A.J., Granger D.N., Grisham M.B., Jourd'Heuil D., Huang P.L., and Lefer D.J. Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am. J. Physiol. 276 5 Pt 2 (1999) H1567-H1573
26. Elrod J.W., Greer J.J., Bryan N.S., Langston W., Szot J.F., Gebregzlabher H., Janssens S., Feelisch M., and Lefer D.J. Cardiomyocyte-specific overexpression of NO synthase-3 protects against myocardial ischemia-reperfusion injury. Arterioscler. Thromb. Vasc. Biol. 26 7 (2006) 1517-1523
27. Jones S.P., Greer J.J., Kakkar A.K., Ware P.D., Turnage R.H., Hicks M., van Haperen R., de Crom R., Kawashima S., Yokoyama M., and Lefer D.J. Endothelial nitric oxide synthase overexpression attenuates myocardial reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 286 1 (2004) H276-H282
28. Laroux F.S., Pavlick K.P., Hines I.N., Kawachi S., Harada H., Bharwani S., Hoffman J.M., and Grisham M.B. Role of nitric oxide in inflammation. Acta Physiol. Scand. 173 1 (2001) 113-118
29. Hines I.N., Kawachi S., Harada H., Pavlick K.P., Hoffman J.M., Bharwani S., Wolf R.E., and Grisham M.B. Role of nitric oxide in liver ischemia and reperfusion injury. Mol. Cell. Biochem. 234-235 1-2 (2002) 229-237
30. Carini R., Grazia De Cesaris M., Splendore R., Domenicotti C., Nitti M.P., Pronzato M.A., and Albano E. Signal pathway responsible for hepatocyte preconditioning by nitric oxide. Free Radic Biol. Med. 34 8 (2003) 1047-1055
31. Pabla R., Buda A.J., Flynn D.M., Blesse S.A., Shin A.M., Curtis M.J., and Lefer D.J. Nitric oxide attenuates neutrophil-mediated myocardial contractile dysfunction after ischemia and reperfusion. Circ. Res. 78 1 (1996) 65-72
32. Siegfried M.R., Carey C., Ma X.L., and Lefer A.M. Beneficial effects of SPM-5185, a cysteine-containing NO donor in myocardial ischemia-reperfusion. Am J Physiol 263 3 Pt 2 (1992) H771-H777
33. Hataishi R., Rodrigues A.C., Neilan T.G., Morgan J.G., Buys E., Shiva S., Tambouret R., Jassal D.S., Raher M.J., Furutani E., Ichinose F., Gladwin M.T., Rosenzweig A., Zapol W.M., Picard M.H., Bloch K.D., and Scherrer-Crosbie M. Inhaled nitric oxide decreases infarction size and improves left ventricular function in a murine model of myocardial ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 291 1 (2006) H379-H384
34. Bolli R. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J. Mol. Cell. Cardiol. 33 11 (2001) 1897-1918
35. Matheis G., Sherman M.P., Buckberg G.D., Haybron D.M., Young H.H., and Ignarro L.J. Role of l-arginine-nitric oxide pathway in myocardial reoxygenation injury. Am. J. Physiol. 262 2 Pt 2 (1992) H616-H620
36. Depre C., Vanoverschelde J.L., Goudemant J.F., Mottet I., and Hue L. Protection against ischemic injury by nonvasoactive concentrations of nitric oxide synthase inhibitors in the perfused rabbit heart. Circulation 92 7 (1995) 1911-1918
37. Yasmin W., Strynadka K.D., and Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc. Res. 33 2 (1997) 422-432
38. ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group, Lancet 345(8951) (1995) 669-685.
39. Roberts Jr. J.D., Fineman J.R., Morin III F.C., Shaul P.W., Rimar S., Schreiber M.D., Polin R.A., Zwass M.S., Zayek M.M., Gross I., Heymann M.A., Zapol W.M., and The Inhaled Nitric Oxide Study Group. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. N. Engl. J. Med. 336 9 (1997) 605-610
40. Clark R.H., Kueser T.J., Walker M.W., Southgate W.M., Huckaby J.L., Perez J.A., Roy B.J., Keszler M., Kinsella J.P., and Clinical Inhaled Nitric Oxide Research Group. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. N. Engl. J. Med. 342 7 (2000) 469-474
41. Hunter C.J., Dejam A., Blood A.B., Shields H., Kim-Shapiro D.B., Machado R.F., Tarekegn S., Mulla N., Hopper A.O., Schechter A.N., Power G.G., and Gladwin M.T. Inhaled nebulized nitrite is a hypoxia-sensitive NO-dependent selective pulmonary vasodilator. Nat. Med. 10 10 (2004) 1122-1127
42. Bryan N.S., Calvert J.W., Elrod J.W., Gundewar S., Ji S.Y., and Lefer D.J. Dietary nitrite supplementation protects against myocardial ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 104 48 (2007) 19144-19149
43. Elrod J.W., Calvert J.W., Gundewar S., Bryan N.S., and Lefer D.J. Nitric oxide promotes distant organ protection: evidence for an endocrine role of nitric oxide. Proc. Natl. Acad. Sci. USA 105 32 (2008) 11430-11435
44. Fox-Robichaud A., Payne D., Hasan S.U., Ostrovsky L., Fairhead T., Reinhardt P., and Kubes P. Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds. J. Clin. Invest. 101 11 (1998) 2497-2505
45. Kubes P., Payne D., Grisham M.B., Jourd-Heuil D., and Fox-Robichaud A. Inhaled NO impacts vascular but not extravascular compartments in postischemic peripheral organs. Am. J. Physiol. 277 2 Pt 2 (1999) H676-H682
46. Ng E.S., Jourd'heuil D., McCord J.M., Hernandez D., Yasui M., Knight D., and Kubes P. Enhanced S-nitroso-albumin formation from inhaled NO during ischemia/reperfusion. Circ. Res. 94 4 (2004) 559-565
47. Cosby K., Partovi K.S., Crawford J.H., Patel R.P., Reiter C.D., Martyr S., Yang B.K., Waclawiw M.A., Zalos G., Xu X., Huang K.T., Shields H., Kim-Shapiro D.B., Schechter A.N., Cannon III R.O., and Gladwin M.T. Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 9 12 (2003) 1498-1505
48. Maher A.R., Milsom A.B., Gunaruwan P., Abozguia K., Ahmed I., Weaver R.A., Thomas P., Ashrafian H., Born G.V., James P.E., and Frenneaux M.P. Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 117 5 (2008) 670-677
49. Kozlov A.V., Costantino G., Sobhian B., Szalay L., Umar F., Nohl H., Bahrami S., and Redl H. Mechanisms of vasodilatation induced by nitrite instillation in intestinal lumen: possible role of hemoglobin. Antioxid. Redox Signal. 7 3-4 (2005) 515-521
50. Ishikawa M., Zhang J.H., Nanda A., and Granger D.N. Inflammatory responses to ischemia and reperfusion in the cerebral microcirculation. Front. Biosci. 9 (2004) 1339-1347
51. Kleindorfer D., Kissela B., Schneider A., Woo D., Khoury J., Miller R., Alwell K., Gebel J., Szaflarski J., Pancioli A., Jauch E., Moomaw C., Shukla R., and Broderick J.P. Eligibility for recombinant tissue plasminogen activator in acute ischemic stroke: a population-based study. Stroke 35 2 (2004) e27-e29
52. Jung K.H., Chu K., Lee S.T., Park H.K., Kim J.H., Kang K.M., Kim M., Lee S.K., and Roh J.K. Augmentation of nitrite therapy in cerebral ischemia by NMDA receptor inhibition. Biochem. Biophys. Res. Commun. 378 3 (2009) 507-512
53. Schatlo B., Henning E.C., Pluta R.M., Latour L.L., Golpayegani N., Merrill M.J., Lewin N., Chen Y., and Oldfield E.H. Nitrite does not provide additional protection to thrombolysis in a rat model of stroke with delayed reperfusion. J. Cereb. Blood Flow Metab. 28 3 (2008) 482-489
54. Bederson J.B., Connolly Jr. E.S., Batjer H.H., Dacey R.G., Dion J.E., Diringer M.N., Duldner Jr. J.E., Harbaugh R.E., Patel A.B., and Rosenwasser R.H. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 40 3 (2009) 994-1025
55. Heros R.C., Zervas N.T., and Varsos V. Cerebral vasospasm after subarachnoid hemorrhage: an update. Ann. Neurol. 14 6 (1983) 599-608
56. Kassell N.F., Kongable G.L., Torner J.C., Adams Jr. H.P., and Mazuz H. Delay in referral of patients with ruptured aneurysms to neurosurgical attention. Stroke 16 4 (1985) 587-590
57. Cahill J., Calvert J.W., and Zhang J.H. Mechanisms of early brain injury after subarachnoid hemorrhage. J. Cereb. Blood Flow Metab. 26 11 (2006) 1341-1353
58. Thom T., Haase N., Rosamond W., Howard V.J., Rumsfeld J., Manolio T., Zheng Z.J., Flegal K., O'Donnell C., Kittner S., Lloyd-Jones D., Goff Jr. D.C., Hong Y., Adams R., Friday G., Furie K., Gorelick P., Kissela B., Marler J., Meigs J., Roger V., Sidney S., Sorlie P., Steinberger J., Wasserthiel-Smoller S., Wilson M., and Wolf P. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 113 6 (2006) e85-e151
59. Ting H.H., Yang E.H., and Rihal C.S. Narrative review: reperfusion strategies for ST-segment elevation myocardial infarction. Ann. Intern. Med. 145 8 (2006) 610-617
60. Gonzalez F.M., Shiva S., Vincent P.S., Ringwood L.A., Hsu L.Y., Hon Y.Y., Aletras A.H., Cannon III R.O., Gladwin M.T., and Arai A.E. Nitrite anion provides potent cytoprotective and antiapoptotic effects as adjunctive therapy to reperfusion for acute myocardial infarction. Circulation 117 23 (2008) 2986-2994
61. Heineke J., and Molkentin J.D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell Biol. 7 8 (2006) 589-600
62. Foo R.S., Mani K., and Kitsis R.N. Death begets failure in the heart. J. Clin. Invest. 115 3 (2005) 565-571
63. Cohen-Solal A., Beauvais F., and Logeart D. Heart failure and diabetes mellitus: epidemiology and management of an alarming association. J. Card. Fail. 14 7 (2008) 615-625
64. Modin A., Bjorne H., Herulf M., Alving K., Weitzberg E., and Lundberg J.O. Nitrite-derived nitric oxide: a possible mediator of 'acidic-metabolic' vasodilation. Acta Physiol. Scand. 171 1 (2001) 9-16
65. Dejam A., Hunter C.J., Tremonti C., Pluta R.M., Hon Y.Y., Grimes G., Partovi K., Pelletier M.M., Oldfield E.H., Cannon III R.O., Schechter A.N., and Gladwin M.T. Nitrite infusion in humans and nonhuman primates: endocrine effects, pharmacokinetics, and tolerance formation. Circulation 116 16 (2007) 1821-1831
66. Dias-Junior C.A., Montenegro M.F., Florencio B.C., and Tanus-Santos J.E. Sildenafil improves the beneficial haemodynamic effects of intravenous nitrite infusion during acute pulmonary embolism. Basic Clin. Pharmacol. Toxicol. 103 4 (2008) 374-379
67. Larsen F.J., Ekblom B., Sahlin K., Lundberg J.O., and Weitzberg E. Effects of dietary nitrate on blood pressure in healthy volunteers. N. Engl. J. Med. 355 26 (2006) 2792-2793
68. Webb A.J., Patel N., Loukogeorgakis S., Okorie M., Aboud Z., Misra S., Rashid R., Miall P., Deanfield J., Benjamin N., MacAllister R., Hobbs A.J., and Ahluwalia A. Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 51 3 (2008) 784-790
69. Laubach V.E., and Kron I.L. Pulmonary inflammation after lung transplantation. Surgery 146 1 (2009) 1-4
70. Fan C., Zwacka R.M., and Engelhardt J.F. Therapeutic approaches for ischemia/reperfusion injury in the liver. J. Mol. Med. 77 8 (1999) 577-592
71. Lemasters J.J., and Thurman R.G. Reperfusion injury after liver preservation for transplantation. Annu. Rev. Pharmacol. Toxicol. 37 (1997) 327-338
72. Kupiec-Weglinski J.W., and Busuttil R.W. Ischemia and reperfusion injury in liver transplantation. Transplant. Proc. 37 4 (2005) 1653-1656
73. Koti R.S., Seifalian A.M., and Davidson B.R. Protection of the liver by ischemic preconditioning: a review of mechanisms and clinical applications. Dig. Surg. 20 5 (2003) 383-396
74. Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am. J. Physiol. Gastrointest. Liver Physiol. 284 1 (2003) G15-G26
75. Selzner M., and Clavien P.A. Fatty liver in liver transplantation and surgery. Semin. Liver Dis. 21 1 (2001) 105-113
76. Fondevila C., Busuttil R.W., and Kupiec-Weglinski J.W. Hepatic ischemia/reperfusion injury - a fresh look. Exp. Mol. Pathol. 74 2 (2003) 86-93
77. Date H., Triantafillou A.N., Trulock E.P., Pohl M.S., Cooper J.D., and Patterson G.A. Inhaled nitric oxide reduces human lung allograft dysfunction. J. Thorac. Cardiovasc. Surg. 111 5 (1996) 913-919
78. Yerebakan C., Ugurlucan M., Bayraktar S., Bethea B.T., and Conte J.V. Effects of inhaled nitric oxide following lung transplantation. J. Card. Surg. 24 3 (2009) 269-274
79. Lang Jr. J.D., Teng X., Chumley P., Crawford J.H., Isbell T.S., Chacko B.K., Liu Y., Jhala N., Crowe D.R., Smith A.B., Cross R.C., Frenette L., Kelley E.E., Wilhite D.W., Hall C.R., Page G.P., Fallon M.B., Bynon J.S., Eckhoff D.E., and Patel R.P. Inhaled NO accelerates restoration of liver function in adults following orthotopic liver transplantation. J. Clin. Invest. 117 9 (2007) 2583-2591
80. Milkiewicz M., Ispanovic E., Doyle J.L., and Haas T.L. Regulators of angiogenesis and strategies for their therapeutic manipulation. Int. J. Biochem. Cell Biol. 38 3 (2006) 333-357
81. Cooke J.P. NO and angiogenesis. Atheroscler. Suppl. 4 4 (2003) 53-60
82. Papapetropoulos A., Garcia-Cardena G., Madri J.A., and Sessa W.C. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J. Clin. Invest. 100 12 (1997) 3131-3139
83. Kumar D., Branch B.G., Pattillo C.B., Hood J., Thoma S., Simpson S., Illum S., Arora N., Chidlow Jr. J.H., Langston W., Teng X., Lefer D.J., Patel R.P., and Kevil C.G. Chronic sodium nitrite therapy augments ischemia-induced angiogenesis and arteriogenesis. Proc. Natl. Acad. Sci. USA 105 21 (2008) 7540-7545